Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Parkinson DiseaseBrain StimulationCerebellum
Interventions
DEVICE

Transcranial direct current stimulation at 2 mA

Uses weak electrical current (2 mA intensity) to either increase or decrease brain excitability and improve functional or cognitive outcomes.

DEVICE

Transcranial direct current stimulation at 4 mA

Uses weak electrical current (4 mA intensity) to either increase or decrease brain excitability and improve functional or cognitive outcomes.

DEVICE

Sham transcranial direct current stimulation

Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Thorsten Rudroff

OTHER

NCT04046055 - Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease | Biotech Hunter | Biotech Hunter